Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, for patients with cataracts, according to a press release.
The IOL is designed to provide patients with more uninterrupted light distribution across the full visual range through 94% light utilization and a 16% increase in optical image contrast between distance and intermediate vision. This will be achieved with the Enlighten NXT optical technology, delivering “the highest reported light utilization of any trifocal IOL — and the lowest light scatter,” Alcon said